美诺医疗获得Novo Tellus的大量股权投资，用于全球扩张。 Amsino Medical receives significant equity investment from Novo Tellus for global expansion.

全球医疗耗材设备供应商美诺医疗集团获得全球供应链领先投资公司Novo Tellus的重大投资。 Amsino Medical Group, a global provider of medical consumable devices, has received a significant investment from Novo Tellus, a leading investment firm in the global supply chain. 此次合作旨在扩大 Amsino 的全球生产、研发和对质量的承诺，投资完全以股权形式进行，并于 2024 年 6 月完成。 The partnership aims to expand Amsino's global production, R&D, and commitment to quality, with the investment made entirely with equity and closing in June 2024. Novo Tellus 此前曾于 2011 年至 2017 年期间与 Amsino 合作，并在此期间实现了大幅增长。 Novo Tellus previously partnered with Amsino between 2011 and 2017, leading to substantial growth during that time.